The global epilepsy treatment devices market is witnessing steady growth as new and innovative therapies emerge to help manage seizures and improve the quality of life for epilepsy patients. With a rising incidence of epilepsy worldwide, advancements in neuromodulation therapies, and increasing adoption of neurostimulation devices, the market is projected to expand significantly in the coming years. According to the latest market report, the global epilepsy treatment devices market was valued at USD 636.11 million in 2024 , and is expected to grow from USD 676.50 million in 2025 to USD 1,202.48 million by 2034 , reflecting a compound annual growth rate (CAGR) of 6.6% during the forecast period. Market Overview Epilepsy is one of the most common neurological disorders, affecting approximately 50 million people worldwide. It is characterized by recurrent and unprovoked seizures, which can significantly impact a patient's physical and mental well-being. While anti-epilept...